Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studied the role of cytokines in growth hormone suppression in premenopausal women with rheumatoid arthritis and evaluated the effect o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Rheumatoid Arthritis, Healthy | Phase 2 | Status: COMPLETED